10 October 2024

PBS Pharmaceuticals Psoriatic Athritis Spondyloarthritis

Bimekizumab added to PBS for PsA and axSpA patients

9 May 2024

Pharmaceuticals Psoriatic Athritis Spondyloarthritis

TGA approves bimekizumab for PsA and axSpA

15 November 2023

ACR Spondyloarthritis

Old dogs, new tricks in spondyloarthropathies

1 June 2023

EULAR Spondyloarthritis

EULAR refocuses on coalface patient care

15 December 2022

Diagnostics PBS Rheumatoid Arthritis Ross River Virus Spondyloarthritis

Rheumatology Republic year in review

15 December 2022

Diet Exercise Spondyloarthritis

Vegetarian diet lessens severity of rheumatoid arthritis

8 December 2022

Spondyloarthritis

Workplace inhalants linked to rheumatoid arthritis

8 December 2022

Ankylosing Spondylitis Biosimilars Scleroderma Spondyloarthritis

Good news: you’re trusted

8 December 2022 SPONSORED

Gout Spondyloarthritis

Behind the JAKi debate

24 November 2022

Osteoporosis Spondyloarthritis

What’s hot in RA research

17 November 2022

Spondyloarthritis

Preclinical RA: an ACR roundup

14 November 2022

Reactive Arthritis Spondyloarthritis

Secrets, myths and pearls

13 November 2022

Spondyloarthritis

Highlights of ACR Day 1

13 November 2022

Spondyloarthritis

Six months of abatacept to prevent RA

10 November 2022

Spondyloarthritis

ACR launch guideline with just one strong recommendation

27 October 2022

Spondyloarthritis

RA remission criteria expanded